Synapse - Population Sciences Research Program

Results (26)

Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry

Meeting Abstract

Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Heart dose is a dosimetric predictor of overall survival in patients with NSCLC undergoing post-operative radiation therapy

Meeting Abstract

Shepherd, A.; Yu, A.; Al-Sadawi, M.; Peleg, A.; Iocolano, M.; Leeman, J.; Imber, B.; Wild, A.; Offin, M.; Chaft, J.; more...
Journal of Thoracic Oncology (2021)

Fulltext@MSK | Save

Inherited rare, deleterious variants in ATM increase lung adenocarcinoma risk

Journal Article

Esai Selvan, M.; Zauderer, M. G.; Rudin, C. M.; Jones, S.; Mukherjee, S.; Offit, K.; Onel, K.; Rennert, G.; Velculescu, V. E.; Lipkin, S. M.; more...
Journal of Thoracic Oncology (2020)

Fulltext@MSK | Save

Novel germline mutations in DNA damage repair in patients with malignant pleural mesotheliomas

Journal Article

Guo, R.; DuBoff, M.; Jayakumaran, G.; Kris, M. G.; Ladanyi, M.; Robson, M. E.; Mandelker, D.; Zauderer, M. G.
Journal of Thoracic Oncology (2020)

Fulltext@MSK | Save

Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations

Journal Article

Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes

Journal Article

Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Detecting HER2 alterations by next generation sequencing (NGS) in patients with advanced NSCLC from the United States and China

Meeting Abstract

Xu, C.; Zhang, Y.; Liu, D.; Shen, R.; Razavi, P.; Liu, S.; Sun, H.; Offin, M.; Drilon, A.; Rudin, C.; more...
Journal of Thoracic Oncology (2018)

Fulltext@MSK | Save

Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial

Meeting Abstract

Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; more...
Journal of Thoracic Oncology (2018)

Fulltext@MSK | Save

Utility of cfDNA testing for acquired resistance: The Memorial Sloan Kettering experience with plasma EGFR T790M clinical testing

Meeting Abstract

Offin, M.; Myers, M.; Josyula, S.; Shen, R.; Borsu, L.; Tsui, D.; Riely, G.; Rudin, C.; Yu, H.; Li, B.; more...
Journal of Thoracic Oncology (2018)

Fulltext@MSK | Save

Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB

Meeting Abstract

Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
Journal of Thoracic Oncology (2018)

Fulltext@MSK | Save